Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8 + and CD4 + T Cells

EBioMedicine

Volumn 5, Issue , 2016, Pages 46-58

  Yin, Wenjie ^a,b   Gorvel, Laurent ^c   Zurawski, Sandra ^a   Li, Dapeng ^a   Ni, Ling ^a   Duluc, Dorothée ^a   Upchurch, Katherine ^a,b   Kim, JongRok ^a   Gu, Chao ^a,b   Ouedraogo, Richard ^a   Wang, Zhiqing ^a   Xue, Yaming ^a   Joo, HyeMee ^a,b   Gorvel, Jean Pierre ^d   Zurawski, Gerard ^a,b   Oh, SangKon ^a,b  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b BAYLOR UNIVERSITY   (United States)

^c AIX MARSEILLE UNIVERSITÉ   (France)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

CD40; Cross presentation; Dendritic cell; Lectins; Vaccine

Indexed keywords

ANTIBODY CONJUGATE; CD14 ANTIGEN; CD40 LIGAND; DECTIN 1; DECTIN 2; EARLY ENDOSOME ANTIGEN 1; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; RECOMBINANT PROTEIN; VIRUS PROTEIN; FUSION PROTEIN; LECTIN; OLR1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE CELL FUNCTION ASSAY; LYMPHOCYTE PROLIFERATION; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; ACTIVE IMMUNOTHERAPY; ANIMAL; CELL DIFFERENTIATION; DENDRITIC CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY, ACTIVE; LECTINS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; RECOMBINANT FUSION PROTEINS; SCAVENGER RECEPTORS, CLASS E;

EID: 84957085357     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.01.029     Document Type: Article

References (61)

1. Belizaire R., Unanue E.R. Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:17463-17468.
2. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998, 393:478-480.
3. + T cell tolerance. J. Exp. Med. 2002, 196:1627-1638.
4. Bonifaz L.C., Bonnyay D.P., Charalambous A., Darguste D.I., Fujii S., Soares H., Brimnes M.K., Moltedo B., Moran T.M., Steinman R.M. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 2004, 199:815-824.
5. Burgdorf S., Kautz A., Bohnert V., Knolle P.A., Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007, 316:612-616.
6. Burgdorf S., Scholz C., Kautz A., Tampe R., Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat. Immunol. 2008, 9:558-566.
7. Caminschi I., Proietto A.I., Ahmet F., Kitsoulis S., Shin Teh J., Lo J.C., Rizzitelli A., Wu L., Vremec D., van Dommelen S.L., Campbell I.K., Maraskovsky E., Braley H., Davey G.M., Mottram P., van de Velde N., Jensen K., Lew A.M., Wright M.D., Heath W.R., Shortman K., Lahoud M.H. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008, 112:3264-3273.
8. + T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J. Immunol. 2006, 177:2276-2284.
9. Castro F.V., Tutt A.L., White A.L., Teeling J.L., James S., French R.R., Glennie M.J. CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses. Eur. J. Immunol. 2008, 38:2263-2273.
10. Chatterjee B., Smed-Sorensen A., Cohn L., Chalouni C., Vandlen R., Lee B.C., Widger J., Keler T., Delamarre L., Mellman I. Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells. Blood 2012, 120:2011-2020.
11. + dendritic cells at cross presentation. J. Exp. Med. 2013, 210:1049-1063.
12. Datta S.K., Redecke V., Prilliman K.R., Takabayashi K., Corr M., Tallant T., DiDonato J., Dziarski R., Akira S., Schoenberger S.P., Raz E. A subset of toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J. Immunol. 2003, 170:4102-4110.
13. Delamarre L., Mellman I. Harnessing dendritic cells for immunotherapy. Semin. Immunol. 2011, 23:2-11.
14. Delamarre L., Holcombe H., Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 2003, 198:111-122.
15. Delneste Y. Scavenger receptors and heat-shock protein-mediated antigen cross-presentation. Biochem. Soc. Trans. 2004, 32:633-635.
16. Delneste Y., Magistrelli G., Gauchat J., Haeuw J., Aubry J., Nakamura K., Kawakami-Honda N., Goetsch L., Sawamura T., Bonnefoy J., Jeannin P. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002, 17:353-362.
17. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., Cheong C., Liu K., Lee H.W., Park C.G., Steinman R.M., Nussenzweig M.C. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315:107-111.
18. Duluc D., Joo H., Ni L., Yin W., Upchurch K., Li D., Xue Y., Klucar P., Zurawski S., Zurawski G., Oh S. Induction and activation of human Th17 by targeting antigens to dendritic cells via dectin-1. J. Immunol. 2014, 192:5776-5788.
19. + T cells while Langerhans cells induce cross-tolerance. EMBO Mol. Med. 2014, 6:1638.
20. + T cells. AIDS 2013, 27:2041-2051.
21. Flamar A.L., Zurawski S., Scholz F., Gayet I., Ni L., Li X.H., Klechevsky E., Quinn J., Oh S., Kaplan D.H., Banchereau J., Zurawski G. Noncovalent assembly of anti-dendritic cell antibodies and antigens for evoking immune responses in vitro and in vivo. J. Immunol. 2012, 189:2645-2655.
22. Fujikado N., Saijo S., Yonezawa T., Shimamori K., Ishii A., Sugai S., Kotaki H., Sudo K., Nose M., Iwakura Y. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 2008, 14:176-180.
23. Geijtenbeek T.B., Gringhuis S.I. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 2009, 9:465-479.
24. Gurer C., Strowig T., Brilot F., Pack M., Trumpfheller C., Arrey F., Park C.G., Steinman R.M., Munz C. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood 2008, 112:1231-1239.
25. Harding C.V., Collins D.S., Slot J.W., Geuze H.J., Unanue E.R. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell 1991, 64:393-401.
26. Idoyaga J., Cheong C., Suda K., Suda N., Kim J.Y., Lee H., Park C.G., Steinman R.M. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol. 2008, 180:3647-3650.
27. Idoyaga J., Lubkin A., Fiorese C., Lahoud M.H., Caminschi I., Huang Y., Rodriguez A., Clausen B.E., Park C.G., Trumpfheller C., Steinman R.M. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:2384-2389.
28. Igyarto B.Z., Haley K., Ortner D., Bobr A., Gerami-Nejad M., Edelson B.T., Zurawski S.M., Malissen B., Zurawski G., Berman J., Kaplan D.H. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 2011, 35:260-272.
29. + T lymphocytes. Nature 2003, 421:852-856.
30. Joo H., Li D., Dullaers M., Kim T.W., Duluc D., Upchurch K., Xue Y., Zurawski S., Le Grand R., Liu Y.J., Kuroda M., Zurawski G., Oh S. C-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B Cell responses. Immunity 2014, 41:592-604.
31. Joo H., Upchurch K., Zhang W., Ni L., Li D., Xue Y., Li X.H., Hori T., Zurawski S., Liu Y.J., Zurawski G., Oh S. Opposing roles of dectin-1 expressed on human plasmacytoid dendritic cells and myeloid dendritic cells in Th2 polarization. J. Immunol. 2015, 195:1723-1731.
32. + T cells by exogenous cell-associated antigens. Immunity 2002, 17:211-220.
33. Kastenmuller W., Kastenmuller K., Kurts C., Seder R.A. Dendritic cell-targeted vaccines-hope or hype?. Nat. Rev. Immunol. 2014, 14:705-711.
34. + T cells by targeting antigens to human dendritic cells through DCIR. Blood 2010, 116:1685-1697.
35. Lahoud M.H., Proietto A.I., Ahmet F., Kitsoulis S., Eidsmo L., Wu L., Sathe P., Pietersz S., Chang H.W., Walker I.D., Maraskovsky E., Braley H., Lew A.M., Wright M.D., Heath W.R., Shortman K., Caminschi I. The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses. J. Immunol. 2009, 182:7587-7594.
36. Lee L.Y., Ha do L.A., Simmons C., de Jong M.D., Chau N.V., Schumacher R., Peng Y.C., McMichael A.J., Farrar J.J., Smith G.L., Townsend A.R., Askonas B.A., Rowland-Jones S., Dong T. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 2008, 118:3478-3490.
37. LeibundGut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., Reis e Sousa C. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007, 8:630-638.
38. + T cells. J. Exp. Med. 2012, 209:109-121.
39. Maurer T., Heit A., Hochrein H., Ampenberger F., O'Keeffe M., Bauer S., Lipford G.B., Vabulas R.M., Wagner H. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells. Eur. J. Immunol. 2002, 32:2356-2364.
40. McMichael A.J., Michie C.A., Gotch F.M., Smith G.L., Moss B. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J. Gen. Virol. 1986, 67(Pt 4):719-726.
41. Meyer-Wentrup F., Benitez-Ribas D., Tacken P.J., Punt C.J., Figdor C.G., de Vries I.J., Adema G.J. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 2008, 111:4245-4253.
42. + T cell responses. J. Immunol. 2010, 185:3504-3513.
43. Reddy M.P., Kinney C.A., Chaikin M.A., Payne A., Fishman-Lobell J., Tsui P., Dal Monte P.R., Doyle M.L., Brigham-Burke M.R., Anderson D., Reff M., Newman R., Hanna N., Sweet R.W., Truneh A. Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J. Immunol. 2000, 164:1925-1933.
44. Reuter A., Panozza S.E., Macri C., Dumont C., Li J., Liu H., Segura E., Vega-Ramos J., Gupta N., Caminschi I., Villadangos J.A., Johnston A.P., Mintern J.D. Criteria for dendritic cell receptor selection for efficient antibody-targeted vaccination. J. Immunol. 2015, 194:2696-2705.
45. + T-helper and a T-killer cell. Nature 1998, 393:474-478.
46. Rosalia R.A., Cruz L.J., van Duikeren S., Tromp A.T., Silva A.L., Jiskoot W., de Gruijl T., Lowik C., Oostendorp J., van der Burg S.H., Ossendorp F. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses. Biomaterials 2015, 40:88-97.
47. Sancho D., Mourao-Sa D., Joffre O.P., Schulz O., Rogers N.C., Pennington D.J., Carlyle J.R., Reis e Sousa C. Tumor therapy in mice via antigen targeting to a novel, DC-Restricted C-type lectin. J. Clin. Invest. 2008, 118:2098-2110.
48. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998, 393:480-483.
49. Schulz O., Diebold S.S., Chen M., Naslund T.I., Nolte M.A., Alexopoulou L., Azuma Y.-T., Flavell R.A., Liljestrom P., Reis e Sousa C. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005, 433:887-892.
50. Segura E., Villadangos J.A. Antigen presentation by dendritic cells in vivo. Curr. Opin. Immunol. 2009, 21:105-110.
51. Skinner J.A., Zurawski S.M., Sugimoto C., Vinet-Oliphant H., Vinod P., Xue Y., Russel-Lodrigue K., Albrecht R.A., Garcia-Sastre A., Salazar A.M., Roy C.J., Kuroda M.J., Oh S., Zurawski G. Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza vaccine assessment. Clin. Vaccine Immunol. 2014.
52. Tacken P.J., de Vries I.J., Gijzen K., Joosten B., Wu D., Rother R.P., Faas S.J., Punt C.J., Torensma R., Adema G.J., Figdor C.G. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 2005, 106:1278-1285.
53. Tacken P.J., de Vries I.J., Torensma R., Figdor C.G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 2007, 7:790-802.
54. Tacken P.J., Ginter W., Berod L., Cruz L.J., Joosten B., Sparwasser T., Figdor C.G., Cambi A. Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation. Blood 2011, 118:4111-4119.
55. Townsend A.R., Skehel J.J. Influenza A specific cytotoxic T-cell clones that do not recognize viral glycoproteins. Nature 1982, 300:655-657.
56. + T cell responses with broad antigen specificity. J. Immunol. 2011, 186:1218-1227.
57. Watts C., Zaru R., Prescott A.R., Wallin R.P., West M.A. Proximal effects of toll-like receptor activation in dendritic cells. Curr. Opin. Immunol. 2007, 19:73-78.
58. Weck M.M., Appel S., Werth D., Sinzger C., Bringmann A., Grunebach F., Brossart P. hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood 2008, 111:4264-4272.
59. + T Cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion. J. Immunol. 2010, 185:6013-6022.
60. Williams B.J., Bhatia S., Adams L.K., Boling S., Carroll J.L., Li X.L., Rogers D.L., Korokhov N., Kovesdi I., Pereboev A.V., Curiel D.T., Mathis J.M. Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector. PLoS One 2012, 7.
61. Zehner M., Chasan A.I., Schuette V., Embgenbroich M., Quast T., Kolanus W., Burgdorf S. Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:9933-9938.